Press release
Targeted Cancer Therapies Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Targeted cancer therapies market is growing due to the increasing incidences of cancers such as breast cancer, lung cancer, colorectal cancer, gastrointestinal cancer and among others. According to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in U.S. and 5,95,690 people died from the disease. However, increasing cancer research funding, rising insurance coverage and increase in number of new targeted anti-cancer drugs supports the revenue growth of targeted cancer therapies market. National Cancer Institute, in 2015, spent around US$ 4,480 million on cancer research which include lung cancer, colorectal cancer, liver cancer, breast cancer, leukemia, ovarian cancer, uterine cancer, and cervical cancer. In addition, according to the American Cancer Society, U.S. has spent around US$ 87.8 billion in 2014 on cancer research, in which the major cost accounting for around 44%, was paid by private insurance companies. Conversely, high prices associated with targeted therapies is expected to hamper the growth of targeted cancer therapies market.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/931
Targeted Cancer Therapies Market Taxonomy:
On the basis of type, the global targeted cancer therapies market is segmented into:
Monoclonal antibodies
Immunotherapy
Antibody-Drug Conjugate (ADC)
Others
On the basis of application, the global targeted cancer therapies market is segmented into:
Breast cancer
Colorectal cancer
Lung cancer
Melanoma
Gastrointestinal
Others (Leukemia, Lymphoma, Prostate cancer)
Increased cost of therapy is a major constraint factor in the targeted cancer therapies market
According to the American Institute of Cancer Research (AICR), in U.S., cancer treatment costs more than any other disease, accounted for around US$ 895 billion a year. According to the study published in the Journal of Clinical Oncology, in 2015, targeted therapies accounted for 63% of the all chemotherapy expenditures in the U.S. in 2011. This further propels the targeted cancer therapies market in the near future. Targeted therapy drugs are very expensive, costs more than US$ 14,000 per patient in the initial stage of treatment. Various insurance companies cover the targeted therapy drugs that are taken orally according to the prescription. However, drugs that are given intravenously are covered in a different way by insurance plans, wherein patient end up paying more money. According to report published in the Journal of Clinical Oncology, in 2015, expenditure for cancer drugs has significantly increased to around US$ 200 for oral drugs per patient per month and around US$ 900 for targeted intravenous anti-cancer therapy per month. According to a study by US National Bureau of Economic Research, in 2015, prices of cancer drugs have increased 10% every year between 1995 and 2013. Rising cost of targeted oral anticancer medicines is a major factor in rising overall cost of targeted cancer therapies.
Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/targeted-cancer-therapies-market-931
Key Players in the Global Targeted Cancer Therapies Market
Some of the key players operating in the targeted cancer therapies market include Abbott Laboratories, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, AstraZeneca PLC, OncoGenex Pharmaceuticals Inc., Pfizer, Inc., AVEO Pharmaceuticals Inc., and CYTOKINETICS INC.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted Cancer Therapies Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here
News-ID: 792569 • Views: …
More Releases from Biotechnology by CMI
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management
Multiple sclerosis (MS) is a disabling autoimmune disease affecting the brain and the spinal cord, eventually causing nerve deterioration or permanent damage. The types of MS include relapsing-remitting MS (RRMS), primary progressive MS (PPMS) and secondary progressive MS (SPMS). RPMS is the most common type characterized by defined attacks with increasing neurological symptoms, PPMS is the rare form characterized by gradual progression…
Ebola Vaccine Market - Global Industry Insights, 2017-2025
Increasing number of Ebola cases in affected regions and new vaccine development for this are expected to be factors driving growth of the market
Increasing mortality rates due to Ebola is expected to be a major factor for growth of the market. According to World Health Organization, in January 2018, around 50% people infected with EVD, have died. African countries such as Siberia, Sierra Leone, Guinea, Democratic Republic of Congo, Senegal,…
Oncology Biosimilars Market-Opportunity Analysis, 2017-2025
Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and some are in its period of expiry. As more products are expected to lose patents, biosimilar is expected to gain popularity. Leading generic players such as Mylan N.V., Teva Pharmaceutical Industries…
Kidney Transplant Holds The Maximum Share Of Organ Transplant Market Due To Risi …
Organ transplantation is the surgical operation in which a healthy organ is removed from one person and transplanted to another person whose organ is failed or damaged. In the organ transplantation, the donated organ may be from living donor, deceased donor, or from an animal. Whereas in some cases an artificial organ is used in the transplantation procedure. Organ transplantation gives new life to the individual with damaged or failed…
More Releases for Targeted
MAAT Debuts Targeted Subliminal Audio Processor
Company releases dedicated plug-in for the psychoacoustic enhancement of audio content
MAAT Labs, a manufacturer of exceptional fidelity professional audio solutions, today announced the introduction of their second generation FiDef JENtwo professional audio software. The new product is the culmination of a seven-year journey to bring a fundamentally new and novel tool for audio enhancement to wider audiences.
In close collaboration with FideliQuest Incorporated, FiDef JENtwo is a 64 bit audio plug-in…
Targeted Protein Degradation Market, 2021-2030
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare
London
Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings.
Small-molecule-induced protein degradation has been demonstrated to possess the potential to drug a broader range of proteinaceous biological targets. It involves the…
Targeted Therapeutics: Technology and Market Dynamics
Targeted therapies are drugs or other substances that block the growth of unwanted cells and pathogens by interfering with specific molecules ("molecular targets") involved in the growth, progression, and spread of disease. Targeted therapies are sometimes called molecularly targeted drugs, molecularly targeted therapies, precision medicines, etc. The emerging field of target therapeutics offers varied potential treatments. Target therapies involves a wide range of therapies, such as, gene therapy, which uses…
Targeted Advertising Solutions Market - Rising Demand from the Providers of Targ …
The rising popularity of digital channels such as mobile and online for media and entertainment, and communications, coupled with their capability to identify and benefit from tracking customer behavior accurately, have created major interest and increasing investments by advertisers on targeted advertising.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47862
Organizations making an entry into the advertising value network need to effectively educate, engage, and create alertness to the advantages of targeted…
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of…
Quality assurance – better targeted than ever
Moehrendorf, 28 July 2016 – “Testing properly – Testing what matters”: Every software QA expert would probably agree with this postulation. But what are the main factors when it comes to dealing with quality assurance and checking the decisive factors? The Software-QS-Tag 2016 provides specific directives for action and new insights from industry, business and research. Germany’s leading conference for SW quality assurance and testing takes place in Nuremberg on…
